Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Chronic kidney disease
Other

Chronic kidney disease

Tracked across 1 events · 12 articles · First seen Jun 03, 2026 · Last active Jun 04, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 0
Tech
Semaglutide Improves Quality of Life
New findings from the landmark FLOW trial, presented at the 63rd ERA Congress in David Farragut, Scotland, revealed that once-weekly Semaglutide significantly improved health-related quality of life in adults with Type 2 diabetes and Chronic…
Impact: Chronic kidney disease is a long-term condition affecting over 850 million people globally, and the FLOW trial's findings on Semaglutide offer a significant improvement in the quality of life for patients with this condition.
Jun 03, 2026 · 12 articles
NEWSDESK
Track Chronic kidney disease live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.